Summary
Carvedilol 12.5, 25 and 50mg was administered once daily for 4 weeks to patients with mild to moderate hypertension. The purpose of the study was to investigate the antihypertensive action of carvedilol when administered once daily and to investigate the pharmacokinetics of carvedilol in patients with mild to moderate hypertension.
Measurable decreases in blood pressure (BP) occurred within 1 hour after the first dose. Peak decreases in supine diastolic blood pressure (DBP) were 9.0 ± 6.8, 15.5 ± 6.7, 14.7 ± 10.6 and 22.5 ± 7.6mm Hg (± SD) for the placebo, 12.5, 25 and 50mg carvedilol groups, respectively, and occurred between 3 and 7 hours after the dose. Administration of carvedilol once daily for 4 weeks kept supine DBP below baseline levels for 24 hours. Trough supine DBP after 4 weeks of treatment were 0.6 ± 6.5, 7.3 ± 7.9, 8.8 ± 7.4 and 12.1 ± 3.8mm Hg (± SD) below baseline. Serum levels of carvedilol were proportional to the dose. Peak serum levels were 39 ± 27, 75 ± 38 and 161 ± 131 μ/L for carvedilol 12.5, 25 and 50mg. The kinetics of carvedilol did not change with repeated administration. Carvedilol was well tolerated; 2 patients experienced dizziness associated with postural hypotension after administration of the 50mg dose. Carvedilol 12.5, 25 and 50mg effectively reduced BP for 24 hours when administered once daily.
Similar content being viewed by others
References
Cubbedu LX, Fuenmayor N, Varin F, Villagra V, Colindres R. Clinical pharmacology of carvedilol in normal volunteers. Clinical Pharmacology and Therapeutics 41: 31–44, 1987
Eggertsen R, Silvertsson R, Andrén L, Hansson L. Hemodynamic effects of combined beta adrenoceptor blockade and precapillary vasodilatation in hypertension. Acta Medica Scandinavica 217 (Suppl. 693): 115–120, 1985
Heber M, Brigden GS, Caruana MP, Lahiri A, Raftery E. Carvedilol for systemic hypertension. American Journal of Cardiology 59: 400–405, 1987
Neugebauer G, Akpan W, von Möllendorf E, Neubert P, Reiff K. Pharmacokinetics and disposition of carvedilol in humans. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): S85–S88, 1987
Strein K, Sponer G, Müller-Beckmann B, Bartsch W. Pharmacological profile of carvedilol, a compound with β-blocking and vasodilating properties. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): S33–S41, 1987
Sundberg S, Tiihonen K, Gordin A. Vasodilatory effects of carvedilol and pindolol. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): S76–S80, 1987
Varin F, Cubbedu LX, Powell JR. Liquid chromatographic assay and disposition of carvedilol in healthy volunteers. Journal of Pharmaceutical Sciences 75: 1195–1197, 1986
von Möllendorf E, Abshagen U, Akpan W, Neugebauer G, Schroeter E. Clinical pharmacologic investigation with carvedilol, a new beta blocker with direct vasodilator activity. Clinical Pharmacology and Therapeutics 39: 677–682, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McPhillips, J.J., Schwemer, G.T., Scott, D.I. et al. Effects of Carvedilol on Blood Pressure in Patients with Mild to Moderate Hypertension. Drugs 36 (Suppl 6), 82–91 (1988). https://doi.org/10.2165/00003495-198800366-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800366-00015